Recently, 3 transcriptional subtypes of human prostate cancer were reported: (i) androgen receptor pathway-positive prostate cancer (ARPC), (ii) mesenchymal and stem-like prostate cancer (MSPC) and (iii) neuroendocrine prostate cancer (NEPC) [6]. This evidence concerns the gene AR and prostate cancer.